Tomasz mroczkowski (42 résultats)

Etat : New.

Etat : New.

Etat : As New. Unread book in perfect condition.

Etat : New.

Etat : New.

Etat : As New. Unread book in perfect condition.

Paperback. Etat : New.

Etat : New.

PF. Etat : New.

Etat : New. This is a Brand-new US Edition. This Item may be shipped from US or any other country as we have multiple locations worldwide.

Etat : Brand New. New. US edition. Expediting shipping for all USA and Europe orders excluding PO Box. Excellent Customer Service.

Etat : As New. Unread book in perfect condition.

Etat : New.

Etat : New. In English.

Paperback. Etat : Very Good. No Jacket. May have limited writing in cover pages. Pages are unmarked. ~ ThriftBooks: Read More, Spend Less.

PAP. Etat : New. New Book. Shipped from UK. Established seller since 2000.

Etat : As New. Unread book in perfect condition.

PAP. Etat : New. New Book. Shipped from UK. Established seller since 2000.

Etat : Used. pp. 288 1st Edition.

Etat : As New. Unread book in perfect condition.

Etat : New.

Etat : New. In English.

Etat : Used. pp. 288.

Etat : New.

Etat : As New. Unread book in perfect condition.

Paperback. Etat : Brand New. 1st edition. 288 pages. 9.00x6.00x0.50 inches. In Stock.

Etat : New. Klappentextrnrn History, Sex and Syphilis: Famous Syphilitics and their Private Lives, by Tomasz F. Mroczkowski, MD, is a fascinating and iconoclastic read. Written by a well-qualified physician and specialist, the author incorporates his exten.

Hardback. Etat : Good. The global center of gravity in life sciences innovation is rapidly shifting to emerging economies. In The New Players in Life Science Innovation, Tomasz Mroczkowski explains how China and other new economic powers are rapidly gaining leadership positions, and thoroughly assesses the implications. Mroczkowski discusses the sophisticated innovation strategies and reforms these nations have implemented: approaches that don't rely on market forces alone, and are achieving remarkable success. Next, he previews the emerging global "bio-economy," in which life science discoveries will be applied pervasively in markets ranging from health to fuels. As R&D in the West becomes increasingly costly, Mroczkowski introduces new options for partnering with new players in the field. He thoroughly covers the globalization of clinical trials, showing how it offers opportunities that go far beyond cost reduction, and assessing the unique challenges it presents. Offering examples from China to Dubai to India, he carefully assesses the business models driving today's newest centers of innovation. Readers will find up-to-date coverage of bioparks, technology zones, and emerging clusters, and realistic assessments of global R&D collaboration strategies such as those of Eli Lilly, Merck, Novartis, and IBM. With innovation-driven industries increasingly dominating the global economy, this book's insights are indispensable for every R&D decision-maker and investor.…

Buch. Etat : Neu. Neuware - 'History, Sex and Syphilis: Famous Syphilitics and their Private Lives,' by Tomasz F. Mroczkowski, MD, is a fascinating and iconoclastic read. Written by a well-qualified physician and specialist, the author incorporates his extensive knowledge of the history of the disease with the private lives of the great writers, musicians, and artists who shaped Western Civilization, and who suffered from a disease that still too little is known about.…

Hardback. Etat : Good. The global center of gravity in life sciences innovation is rapidly shifting to emerging economies. In The New Players in Life Science Innovation, Tomasz Mroczkowski explains how China and other new economic powers are rapidly gaining leadership positions, and thoroughly assesses the implications. Mroczkowski discusses the sophisticated innovation strategies and reforms these nations have implemented: approaches that don't rely on market forces alone, and are achieving remarkable success. Next, he previews the emerging global "bio-economy," in which life science discoveries will be applied pervasively in markets ranging from health to fuels. As R&D in the West becomes increasingly costly, Mroczkowski introduces new options for partnering with new players in the field. He thoroughly covers the globalization of clinical trials, showing how it offers opportunities that go far beyond cost reduction, and assessing the unique challenges it presents. Offering examples from China to Dubai to India, he carefully assesses the business models driving today's newest centers of innovation. Readers will find up-to-date coverage of bioparks, technology zones, and emerging clusters, and realistic assessments of global R&D collaboration strategies such as those of Eli Lilly, Merck, Novartis, and IBM. With innovation-driven industries increasingly dominating the global economy, this book's insights are indispensable for every R&D decision-maker and investor.…